Wall Street analysts forecast that Equifax Inc. (NYSE:EFX) will post earnings per share (EPS) of $1.36 for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Equifax’s earnings, with the highest EPS estimate coming in at $1.38 and the lowest estimate coming in at $1.33. Equifax posted earnings of $1.56 per share during the same quarter last year, which would indicate a negative year over year growth rate of 12.8%. The business is scheduled to issue its next quarterly earnings results on Wednesday, July 24th.
According to Zacks, analysts expect that Equifax will report full-year earnings of $5.63 per share for the current fiscal year, with EPS estimates ranging from $5.60 to $5.70. For the next year, analysts expect that the business will post earnings of $6.15 per share, with EPS estimates ranging from $5.90 to $6.30. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that cover Equifax.
Equifax (NYSE:EFX) last released its quarterly earnings results on Friday, May 10th. The credit services provider reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.01. Equifax had a positive return on equity of 21.95% and a negative net margin of 10.23%. The company had revenue of $846.10 million during the quarter, compared to analysts’ expectations of $850.07 million. During the same period last year, the business posted $1.43 earnings per share. The firm’s revenue was down 2.3% compared to the same quarter last year.
A number of equities research analysts have commented on the company. Royal Bank of Canada set a $184.00 price target on Jazz Pharmaceuticals and gave the company a “buy” rating in a research note on Wednesday, July 3rd. Zacks Investment Research cut HEXO from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. Morgan Stanley increased their price target on Blackstone Group from $54.00 to $56.00 and gave the company an “overweight” rating in a research note on Friday. ValuEngine cut Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, May 28th. Finally, Barclays increased their price target on WEX from $222.00 to $238.00 and gave the company an “overweight” rating in a research note on Monday, May 6th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company’s stock. Equifax has a consensus rating of “Hold” and an average price target of $126.00.
Equifax stock opened at $137.84 on Tuesday. The company has a 50-day simple moving average of $134.10. The company has a debt-to-equity ratio of 1.02, a quick ratio of 0.57 and a current ratio of 0.57. Equifax has a one year low of $88.68 and a one year high of $140.52. The stock has a market capitalization of $16.59 billion, a PE ratio of 23.81, a PEG ratio of 2.85 and a beta of 1.24.
Several hedge funds have recently made changes to their positions in the company. OppenheimerFunds Inc. increased its holdings in shares of Equifax by 0.9% in the first quarter. OppenheimerFunds Inc. now owns 1,737,528 shares of the credit services provider’s stock valued at $205,897,000 after purchasing an additional 15,617 shares during the period. FMR LLC increased its holdings in shares of Equifax by 170.6% in the first quarter. FMR LLC now owns 1,737,197 shares of the credit services provider’s stock valued at $205,857,000 after purchasing an additional 1,095,138 shares during the period. Geode Capital Management LLC increased its holdings in shares of Equifax by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 1,528,538 shares of the credit services provider’s stock valued at $142,098,000 after purchasing an additional 112,467 shares during the period. Northern Trust Corp increased its holdings in shares of Equifax by 1.5% in the first quarter. Northern Trust Corp now owns 1,355,529 shares of the credit services provider’s stock valued at $160,630,000 after purchasing an additional 19,873 shares during the period. Finally, Norges Bank acquired a new position in shares of Equifax in the fourth quarter valued at about $102,210,000. 94.43% of the stock is currently owned by institutional investors and hedge funds.
Equifax Company Profile
Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.
Featured Story: What is total return in investing?
Get a free copy of the Zacks research report on Equifax (EFX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Equifax Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Equifax and related companies with MarketBeat.com’s FREE daily email newsletter.